Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.14
-0.60 (-0.57%)
Sep 2, 2026, 11:32 AM EDT - Market open

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-205.35-196.54-260.6-184.68-181.12-69.61
Depreciation & Amortization
1.081.341.561.761.671.16
Loss (Gain) From Sale of Investments
-6.16-6.52-8.17-9.84-1.27-
Stock-Based Compensation
87.2366.8239.6832.5519.8320.8
Other Operating Activities
21.7920.19103.0719.244.87-100.25
Change in Accounts Receivable
-14.75-7.57-3.65-8.64-5.2-1.25
Change in Inventory
-12.81-7.47-10.12-5.71-2.81-0.01
Change in Accounts Payable
23.1121.8921.9214.771.5418.31
Change in Unearned Revenue
--1.09--0.15-6.61-
Change in Other Net Operating Assets
0.51-6.722.424.53-4.34-15.15
Operating Cash Flow
-105.35-115.68-113.88-136.16-173.43-146
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.95-0.95--0.05-0.28-0.43
Sale (Purchase) of Intangibles
-40-40-40.5-5.67-7
Investment in Securities
-103.98-96.2-7.670.0532.31-163.73
Other Investing Activities
-----495
Investing Cash Flow
-144.94-137.15-48.17-5.6728.03-62.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
211.67237.8856.3957.4141.49166.48
Other Financing Activities
-22.17-19.92-416.9772.34-
Financing Cash Flow
179.79217.96191.2474.37213.83166.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.60.090-0.14--
Net Cash Flow
-69.9-34.7829.19-67.668.43-41.68

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-106.3-116.63-113.88-136.2-173.71-146.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-44.31%-61.46%-87.51%-175.91%-734.87%-4642.90%
Free Cash Flow Per Share
-1.58-1.79-1.87-2.36-3.33-2.95
Levered Free Cash Flow
-130.59-145.98-81.99-91.47-105.11-57.05
Unlevered Free Cash Flow
-119.04-133.12-69.11-82.79-101.86-57.05

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-3.94-0.9710.584.81-17.411.9
SEC Filings: 10-K · 10-Q